홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Potassium Iodide → (6R,7R)-3-[[5-amino-4-(azetidin-3-ylcarbamoylamino)-1-methylpyrazol-2-ium-2-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

HRID 1247821
인쇄

반응식

HRID 1247821 반응식
[NH2:1][C:2]1[S:6][N:5]=[C:4](/[C:7](=[N:34]/[O:35][C:36]([C:39]([O:41]C(C)(C)C)=[O:40])([CH3:38])[CH3:37])/[C:8]([NH:10][C@@H:11]2[C:32](=[O:33])[N:13]3[C:14]([C:20]([O:22]CC4C=CC(OC)=CC=4)=[O:21])=[C:15]([CH2:18]Cl)[CH2:16][S:17][C@H:12]23)=[O:9])[N:3]=1.C[Si](C)(C)NC(=O)C.[I-].[K+].[CH3:56][N:57]1[C:61]([NH:62]C(C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=[C:60]([NH:82][C:83]([NH:85][CH:86]2[CH2:89][N:88](C(OC(C)(C)C)=O)[CH2:87]2)=[O:84])[CH:59]=[N:58]1>CN(C)C=O.C(OCC)(=O)C>[NH2:62][C:61]1[N:57]([CH3:56])[N+:58]([CH2:18][C:15]2[CH2:16][S:17][C@@H:12]3[C@H:11]([NH:10][C:8](=[O:9])/[C:7](/[C:4]4[N:3]=[C:2]([NH2:1])[S:6][N:5]=4)=[N:34]\[O:35][C:36]([C:39]([OH:41])=[O:40])([CH3:37])[CH3:38])[C:32](=[O:33])[N:13]3[C:14]=2[C:20]([O-:22])=[O:21])=[CH:59][C:60]=1[NH:82][C:83]([NH:85][CH:86]1[CH2:89][NH:88][CH2:87]1)=[O:84]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 4875Potassium IodideHCID 25989Acetamide, N-(trimethylsilyl)-HCID 21904516tert-butyl 3-[(([1-methyl-5-(tritylamino)-1H-pyrazol-4-yl]amino}carbonyl)amino]-1-azetidinecarboxylateHCID 87481325Ceftolozane Impurity 20

생성물 1

HCID 141604759
(6R,7R)-3-[[5-amino-4-(azetidin-3-ylcarbamoylamino)-1-methylpyrazol-2-ium-2-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
수율 14.9%

시약·촉매·용매 2

HCID 6228Dimethylformamide용매2회HCID 8857Ethyl Acetate용매

실험 절차

To a solution of 4-methoxybenzyl 7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-tert-butoxycarbonyl-1-methylethoxyimino)acetamido]-3-chloromethyl-3-cephem-4-carboxylate (1.48 g) in N,N-dimethylformamide (3.0 ml) was added N-(trimethylsilyl)acetamide (1.42 g), and the mixture was stirred at room temperature for 30 minutes. To the solution was added potassium-iodide (504 mg) and the mixture was stirred at room temperature for 30 minutes. To the reaction mixture was added a solution of tert-butyl 3-[({[1-methyl-5-(tritylamino)-1H-pyrazol-4-yl]amino}carbonyl)amino]-1-azetidinecarboxylate (1.20 g) in N,N-dimethylformamide (2.2 ml), and the whole mixture was stirred at 50° C. for 16 hours. To the resulting reaction mixture was added ethyl acetate (200 ml), and the solution was washed successively with water (50 ml), 10% aqueous sodium trifluoroacetate solution (50 ml×2) and brine (50 ml), dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated to about 10 ml in vacuo. The concentrate was poured into diisopropyl ether (160 ml), and the resulting precipitate was collected by filtration and dried in vacuo. To a solution of the solid in methylene chloride (8.64 ml) were added anisole (2.88 ml) and trifluoroacetic acid (8.64 ml). The resulting solution was stirred at room temperature for 3 hours and poured into diisopropyl ether (160 ml). The resulting precipitate was collected by filtration and dried in vacuo to give a crude product (2.22 g), which was purified by preparative HPLC utilizing ODS column eluting with a mixture of acetonitrile and phosphate buffer (pH 5.5). The eluate containing a desired product was concentrated to about 20 ml in vacuo. The concentrate was desalted by preparative HPLC utilizing ODS column, and the fraction eluted with 8% aqueous acetonitrile was concentrated to about 10 ml in vacuo and lyophilized to give 3-[(3-amino-4-{[(3-azetidinylamino)carbonyl]amino}-2-methyl-1-pyrazolio)methyl]-7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-carboxy-1-methylethoxyimino)acetamido]-3-cephem-4-carboxylate (220 mg) as an amorphous solid.

후처리

  1. stirringthe mixture was stirred at room temperature for 30 minutes
  2. stirringthe whole mixture was stirred at 50° C. for 16 hours
  3. customTo the resulting reaction mixture
  4. washthe solution was washed successively with water (50 ml), 10% aqueous sodium trifluoroacetate solution (50 ml×2) and brine (50 ml)
  5. dry with materialdried over anhydrous sodium sulfate
  6. filtrationfiltered
  7. concentrationThe filtrate was concentrated to about 10 ml in vacuo
  8. additionThe concentrate was poured into diisopropyl ether (160 ml)
  9. filtrationthe resulting precipitate was collected by filtration
  10. customdried in vacuo
  11. additionTo a solution of the solid in methylene chloride (8.64 ml) were added anisole (2.88 ml) and trifluoroacetic acid (8.64 ml)
  12. stirringThe resulting solution was stirred at room temperature for 3 hours
  13. additionpoured into diisopropyl ether (160 ml)
  14. filtrationThe resulting precipitate was collected by filtration
  15. customdried in vacuo
  16. customto give a crude product (2.22 g), which
  17. customwas purified by preparative HPLC
  18. washeluting with a mixture of acetonitrile and phosphate buffer (pH 5.5)
  19. additionThe eluate containing a desired product
  20. concentrationwas concentrated to about 20 ml in vacuo
  21. washthe fraction eluted with 8% aqueous acetonitrile
  22. concentrationwas concentrated to about 10 ml in vacuo

출처 및 근거

ORD 기록
ord-2f4a86f3d7ce4f2f905feea3ef261f0d
출처 데이터셋
uspto-grants-2006_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07129232B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트